Pulmatrix, Inc (PULM) Stock Price

4.84 ▼ -0.01 (-0.21%)
Open: 4.85 Vol: 3.24K Day's range: 4.78 - 4.91 Oct 24, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PULM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 4.91▼ 4.91▼ 4.86▼ 4.91▼ 4.74▲
MA10 4.88▼ 4.88▼ 4.87▼ 4.86▼ 4.84▲
MA20 4.87▼ 4.86▼ 4.85▼ 4.84▼ 5.52▼
MA50 4.86▼ 4.81▼ 4.82▼ 4.82▲ 6.36▼
MA100 4.88▼ 4.87▼ 4.84▼ 5.69▼ 4.17▲
MA200 5.11▼ 5.41▼ 5.82▼ 6.34▼ 4.10▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.007▼ -0.006▼ -0.007▼ 0.014▲ -0.066▼
RSI 39.591▼ 40.851▼ 42.500▼ 49.515▼ 42.087▼
STOCH 65.175     65.175     48.508     57.155     33.618    
WILL %R -100.000▼ -100.000▼ -100.000▼ -44.633     -74.112    
CCI -198.997▼ -170.586▼ -166.713▼ 20.020     -35.451    
Latest Filters Detected On PULM
MA $PULM Price Crossed Below MA(13) Set Alert
MA $PULM Price Crossed Below MA(7) Set Alert
CDL $PULM Matching Low Candlestick Pattern Detected Set Alert
CDL $PULM Doji Candlestick Pattern Detected Set Alert
Pulmatrix, Inc News
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025
Thursday, October 23, 2025 03:59 AM
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present new research from the company’s cardio-pulmonary portfolio and pipeline at the American Heart ...
OS Therapies Announces Overall and Event Free Survival Key Subgroup Data for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Wednesday, October 22, 2025 07:00 AM
OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced additional overall ...
OS Therapies Granted Final Type C Meeting by U.S. FDA and pre-MAA Meeting by U.K. MHRA for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary ...
Friday, October 17, 2025 06:35 AM
Final FDA Type C Meeting December 11, 2025 - biomarker data to be availableOctober 10, 2025 FDA/Osteosarcoma Institute Workshop narrows focus for OST-HER2 overall survival, biomarker correlation & ...
PULM historical stock data
date open high low close volume
24/10/25 4.85 4.91 4.78 4.84 3,242
23/10/25 4.86 4.8705 4.75 4.85 1,854
22/10/25 4.94 4.94 4.50 4.905 14,252
21/10/25 5.06 5.08 4.81 4.9419 3,657
20/10/25 4.80 5.235 4.80 5.01 38,280
17/10/25 4.8655 4.9575 4.6741 4.8128 12,829
16/10/25 4.62 4.8433 4.58 4.64 39,153
15/10/25 4.9902 5.00 4.68 4.7582 12,874
14/10/25 4.90 4.94 4.85 4.90 4,716
13/10/25 4.99 4.99 4.77 4.90 11,435
Quote Details
52wk Low:2.00
52wk High:10.40
Vol:3.24K
Avg Vol(3m):277K
1Y Chng:+136.10%
1M Chng:-6.74%
Add to Watch List
More Information
Index US Composite
Market Cap. 17.71M